Imexpharm

Imexpharm Altman Z-Score

The Altman Z-Score of Imexpharm (IMP.VN) as of Oct 29, 2026 is 12.02. In the previous year, Altman Z-Score was 16.95 — a change of -29.10% (lower).

Altman Z-Score

12.02

YoY

-29.10%

Last updated:

Altman Z-Score of Imexpharm is 2025 12.02 . Altman Z-Score of Imexpharm was 2024 16.95 . It decreases by -29.10% lower compared to the previous year.

The Imexpharm Altman Z-Score history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Altman Z-Score
Date
Altman Z-Score
Jan 1, 2018
19.36 VND
Jan 1, 2019
18.59 VND
Jan 1, 2020
14.92 VND
Jan 1, 2021
11.15 VND
Jan 1, 2022
14.21 VND
Jan 1, 2023
17.64 VND
Jan 1, 2024
16.95 VND
Jan 1, 2025
12.02 VND
The Imexpharm Altman Z-Score history
YEARAltman Z-ScoreYoY
12.02-29.10%
16.95-3.90%
17.64+24.06%
14.21+27.51%
11.15-25.28%
14.92-19.74%
18.59-3.99%
19.36+38.13%
14.02-41.01%
23.76-14.70%
27.86+23.85%
22.49—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Altman Z-Score of Imexpharm is 12.02 in 2025.

On Eulerpool you can find the complete historical development of Altman Z-Score Imexpharm since 2006 – with annual values, charts, and detailed analysis.

The Altman Z-Score predicts bankruptcy probability using five financial ratios. Scores above 3.0 indicate safety, below 1.8 suggests distress risk.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Imexpharm

All Key Metrics — Imexpharm